Year: 2020

No Picture
Trading Ideas

Boeing Quietly Pulls Plug on the 747, Closing Era of Jumbo Jets

July 2, 2020 admin Comments Off on Boeing Quietly Pulls Plug on the 747, Closing Era of Jumbo Jets

(Bloomberg) — Boeing Co. hasn’t told employees, but the company is pulling the plug on its hulking 747 jumbo jet, ending a half-century run for the twin-aisle pioneer.The last 747-8 will roll out of a Seattle-area factory in about two years, a decision that hasn’t been reported but can be teased out from subtle wording changes in financial statements, people familiar with the matter said.It’s a moment that aviation enthusiasts long have dreaded, signaling the end of the double-decker, four-engine leviathans that shrank the world. Airbus SE is already preparing to build the last A380 jumbo, after the final convoy …read more […]

No Picture
Trading Ideas

Why Netflix (NFLX) Is A Compelling Investment Case

July 2, 2020 admin Comments Off on Why Netflix (NFLX) Is A Compelling Investment Case

If you are looking for the best ideas for your portfolio you may want to consider some of Ensemble Capital’s top stock picks. Ensemble Capital, an investment management firm, is bullish on Netflix Inc (NASDAQ:NFLX) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed its investment […] …read more […]

No Picture
Trading Ideas

Tesla Skeptic Marvels at $48 Billion Boost From One Data Point

July 2, 2020 admin Comments Off on Tesla Skeptic Marvels at $48 Billion Boost From One Data Point

(Bloomberg) — Tesla Inc.’s cars may run on batteries, but its stock price is fueled by “the power of the narrative,” according to an analyst with a sell rating on the shares.In a report Thursday, Joe Spak of RBC Capital Markets marveled at how the electric-car maker has managed to add about $48 billion of market capitalization by ginning up excitement about its quarterly vehicle deliveries.On June 24, Tesla’s investor-relations team shared a collection of delivery estimates that found analysts on average were expecting the company to hand over about 70,300 vehicles to customers. The market recognized this as a …read more […]

No Picture
Trading Ideas

China tech giant Alibaba dismisses livestreaming head, citing nepotism, gifts: document

July 2, 2020 admin Comments Off on China tech giant Alibaba dismisses livestreaming head, citing nepotism, gifts: document

Chinese e-commerce giant Alibaba Group Holding Ltd has fired Zhao Yan, the head of its fast-growing livestreaming division, on grounds of nepotism and accepting gifts, according to an internal memo announcing his termination, seen by Reuters. The undated document, produced by Alibaba’s human resources department and published on June 29 on the company’s internal intranet for staff, says Zhao was fired after he used his position to help third-party livestreamers score favorable positioning on Taobao Live, Alibaba’s main platform for live-streamed e-commerce. …read more […]

No Picture
Trading Ideas

Should Investors Buy the Dip in Starbucks (SBUX) Stock?

July 2, 2020 admin Comments Off on Should Investors Buy the Dip in Starbucks (SBUX) Stock?

If you are looking for the best ideas for your portfolio you may want to consider some of Ensemble Capital’s top stock picks. Ensemble Capital, an investment management firm, is bullish on Starbucks Corp (NASDAQ:SBUX) stock. In its Q4 2019 investor letter – you can download a copy here – the firm discussed its investment […] …read more […]

No Picture
Trading Ideas

FDA Rejects Intercept’s Liver Disease Drug, But This Analyst Still Anticipates Approval

July 2, 2020 admin Comments Off on FDA Rejects Intercept’s Liver Disease Drug, But This Analyst Still Anticipates Approval

No pain, no gain goes the well-worn axiom. A stock market themed inverse can read: no gain, shareholder pain. You can currently apply the latter to Intercept Pharmaceuticals (ICPT). The small-cap biotech was hoping to gain the FDA’s nod of approval for its liver disease therapy, but there was only pain to endure, as the NDA was rejected. As a result, shares were sent tumbling by 40% on Monday June 29. So, what happened exactly? ICPT received a CRL from the FDA regarding its obeticholic acid (OCA) treatment in advanced-stage non-alcoholic steatohepatitis (NASH), due to a lack of evidence showing …read more […]

No Picture
Trading Ideas

The Best Biotech IPOs of 2020 So Far and What’s In Store

July 2, 2020 admin Comments Off on The Best Biotech IPOs of 2020 So Far and What’s In Store

The coronavirus pandemic has ground businesses across the country to a halt.
But the best biotech IPOs and firms have been stomping on the gas pedal. And those who took the leap of faith and invested in them early have been rewarded handsomely.
In June alone, there were no less than 14 IPOs in the sector. And a good chunk of them are outperforming the broader markets.
When Pliant Therapeutics (Nasdaq: PLRX) IPOed, it was fetching $16 per share. Share prices have since jumped close to 70% in less than a month of trading.
Forma Therapeutics (Nasdaq: FMTX), which develops therapies for rare diseases …read more […]

No Picture
Trading Ideas

COVID-19 Creates Long-Term Opportunity for Novavax, Says Analyst

July 2, 2020 admin Comments Off on COVID-19 Creates Long-Term Opportunity for Novavax, Says Analyst

As we enter the second half of the year, pharma companies are still frantically engaged in the search for a COVID-19 vaccine. There are many companies in the mix, but it is not a level playing field, as big players are pitted against smaller names. At the onset of the pandemic, Novavax (NVAX) stood squarely in the latter camp. Facing pharma giants such as Pfizer, AstraZeneca and J&J, the small-cap biotech was at a disadvantage from the start. However, the vaccine specialist has become a force to be reckoned with. The incredible share gains (almost 1,855% year-to-date) which have pushed …read more […]